Insulet (PODD) Research & Development (2010 - 2026)

Insulet (PODD) has 17 years of Research & Development data on file, last reported at $89.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 50.5% year-over-year to $89.7 million; the trailing twelve-month figure through Mar 2026 stood at $331.2 million (up 44.63% YoY), and the FY2025 full-year result was $301.1 million, up 37.11% from the prior year.
• Research & Development for Q1 2026 stood at $89.7 million, down from $90.9 million in the prior quarter.
• Across five years, Research & Development topped out at $90.9 million in Q4 2025 and bottomed at $42.0 million in Q4 2023.
• The 5-year median for Research & Development is $54.9 million (2024), against an average of $58.6 million.
• The widest annual swing landed in 2023, when Research & Development retreated 15.15%; it then surged 50.5% in 2026.
• A 5-year view of Research & Development shows it stood at $49.5 million in 2022, then fell by 15.15% to $42.0 million in 2023, then soared by 44.29% to $60.6 million in 2024, then surged by 50.0% to $90.9 million in 2025, then fell by 1.32% to $89.7 million in 2026.
• The last three Research & Development figures came in at $89.7 million (Q1 2026), $90.9 million (Q4 2025), and $77.2 million (Q3 2025), per Business Quant data.

Peer Comparison